nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author index
|
|
|
2013 |
41 |
S1 |
p. S35-S37 3 p. |
artikel |
2 |
Case-5 THERAPEUTIC HYPOTHERMIA IN THE TREATMENT OF HAEMOPHILUS APHROPHILUS ENDOCARDITIS COMPLICATED WITH ISCHEMIC STROKE
|
Krajinović, V. |
|
2013 |
41 |
S1 |
p. S2- 1 p. |
artikel |
3 |
Editorial Board
|
|
|
2013 |
41 |
S1 |
p. ii- 1 p. |
artikel |
4 |
Introduction
|
|
|
2013 |
41 |
S1 |
p. vii- 1 p. |
artikel |
5 |
P61 ACTIVITY OF DABIGATRAN ETEXILATE AND ABCIXIMAB IN THE PROPHYLAXIS OF EXPERIMENTAL ENDOCARDITIS DUE TO LOW-GRADE BACTEREMIA
|
Veloso, T.R. |
|
2013 |
41 |
S1 |
p. S25- 1 p. |
artikel |
6 |
P40 “ACUTE INFECTIVE ENDOCARDITIS BY AMPLATZER” – ANEW ENTITY: CASE REPORT AND LITERATURE REVIEW
|
Castaneda, X. |
|
2013 |
41 |
S1 |
p. S19- 1 p. |
artikel |
7 |
P65 AMPICILLIN PLUS GENTAMICIN OR AMPICILLIN PLUS DAPTOMYCIN FOR ENTEROCOCCAL INFECTIOUS ENDOCARDITIS: A RETROSPECTIVE COHORT STUDY
|
Tebini, A. |
|
2013 |
41 |
S1 |
p. S26- 1 p. |
artikel |
8 |
P41 AN ALTERNATIVE SUSCEPTIBILITY METHOD AS PREDICTOR OF CLINICAL RESPONSE TO VANCOMYCIN (VAN) WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIVE ENDOCARDITIS (IE)
|
Casapao, A.M. |
|
2013 |
41 |
S1 |
p. S19- 1 p. |
artikel |
9 |
P02 AN EPIDEMIC OF INFECTIVE ENDOCARDITIS AT THE CROSSROADS OF DRUG TRAFFIC
|
Demin, A. |
|
2013 |
41 |
S1 |
p. S7- 1 p. |
artikel |
10 |
P23 A PATIENT WITH ENDOCARDITIS AND CARDIAC MELANOMA METASTASES
|
Vukelić, D. |
|
2013 |
41 |
S1 |
p. S14- 1 p. |
artikel |
11 |
P24 ASSOCIATION BETWEEN VALVULAR SURGERY AND MORTALITY AMONG PATIENTS WITH INFECTIVE ENDOCARDITIS COMPLICATED BY SEVERE SEPSIS AND SEPTIC SHOCK
|
Krajinović, V. |
|
2013 |
41 |
S1 |
p. S14- 1 p. |
artikel |
12 |
P55 CA-MRSA AS A CAUSE OF LEMIERRE'S SYNDROME: FIRST REPORT OF TWO CASES IN ARGENTINA
|
Espinola, L. |
|
2013 |
41 |
S1 |
p. S23- 1 p. |
artikel |
13 |
P44 CANDIDA INFECTIVE ENDOCARDITIS (IE) IN A TERTIARY REFERRAL CARDIAC SURGERY HOSPITAL IN BRAZIL FROM 2006 TO 2012
|
Marques, J. |
|
2013 |
41 |
S1 |
p. S20- 1 p. |
artikel |
14 |
P32 CARDIAC IMPLANTABLE ELECTRONIC DEVICE ENDOCARDITIS: REPORT OF EIGHT CASES
|
Vincelj, J. |
|
2013 |
41 |
S1 |
p. S16- 1 p. |
artikel |
15 |
P34 CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTION, COMPLETE DEVICE REMOVAL FOLLOWED BY LONG TERM ANTIBIOTIC TREATMENT; IS LONGER SAFER?
|
Ihlemann, N. |
|
2013 |
41 |
S1 |
p. S17- 1 p. |
artikel |
16 |
P49 CARDIOVASCULAR SYPHILIS: REPORT OF TWO CASES
|
Jaramillo, N. |
|
2013 |
41 |
S1 |
p. S21- 1 p. |
artikel |
17 |
P16 CHANGING PROFILE OF INFECTIVE ENDOCARDITIS IN A TERTIARY UNIVERSITY HOSPITAL: A 6-YEAR EXPERIENCE (2005–2010)
|
Zarkali, A. |
|
2013 |
41 |
S1 |
p. S12- 1 p. |
artikel |
18 |
P43 CHARACTERIZATION OF AMINOGLYCOSIDE MODIFYING ENZYMES AMONG STAPHYLOCOCCUS AUREUS ISOLATED FROM SURGERY DEPARTMENTS
|
Shaheen, A.A. |
|
2013 |
41 |
S1 |
p. S19-S20 2 p. |
artikel |
19 |
P12 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS AT THE HOSPITAL UNIVERSITARIO CLEMENTINO FRAGA FILHO
|
Querido Fortes, C. |
|
2013 |
41 |
S1 |
p. S10-S11 2 p. |
artikel |
20 |
P10 CONTRIBUTION TO INFECTIVE ENDOCARDITIS BY STREPTOCOCCUS BOVIS IN ALBANIA
|
Kica, Arjana |
|
2013 |
41 |
S1 |
p. S10- 1 p. |
artikel |
21 |
P72 DAPTOMYCIN AS AN OPTION IN LEFT–SIDE INFECTIVE ENDOCARDITIS
|
Tezer Tekçe, A.Y. |
|
2013 |
41 |
S1 |
p. S28- 1 p. |
artikel |
22 |
P92 DAPTOMYCIN (D) IN LEFT–SIDED INFECTIVE ENDOCARDITIS (LSIE)
|
Nacinovich, F. |
|
2013 |
41 |
S1 |
p. S34- 1 p. |
artikel |
23 |
P71 DAPTOMYCIN IN CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE (CIED) ENDOCARDITIS
|
Tezer Tekçe, A.Y. |
|
2013 |
41 |
S1 |
p. S28- 1 p. |
artikel |
24 |
P68 DAPTOMYCIN NON–SUSCEPTIBILITY IN PATIENTS PREVIOUSLY TREATED WITH GLYCOPEPTIDES FOR PROSTHETIC VALVE INFECTIVE ENDOCARDITIS
|
Capone, A. |
|
2013 |
41 |
S1 |
p. S27- 1 p. |
artikel |
25 |
P66 DAPTOMYCIN USE IN INFECTIVE ENDOCARDITIS AT A CARDIAC SURGERY REFERRAL HOSPITAL, 20092012, RIO DE JANEIRO, BRAZIL
|
Parente, A. |
|
2013 |
41 |
S1 |
p. S26- 1 p. |
artikel |
26 |
P60 DEVELOPMENT AND CHARACTERIZATION OF PORCINE MODELS OF NON-BACTERIAL AND STAPHYLOCOCCAL ENDOCARDITIS: HISTOPATHOLOGICAL ASPECTS
|
Christiansen, J.G. |
|
2013 |
41 |
S1 |
p. S24-S25 2 p. |
artikel |
27 |
P30 DEVICE-RELATED INFECTIVE ENDOCARDITIS (IE): ANALYSIS OF CASES FROM A CARDIAC REFERRAL CENTRE IN RIO DE JANEIRO, 2006–2012
|
Lima, M. |
|
2013 |
41 |
S1 |
p. S15-S16 2 p. |
artikel |
28 |
P58 DIVERSITY OF VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS IN CROATIA
|
Bukovski, S. |
|
2013 |
41 |
S1 |
p. S24- 1 p. |
artikel |
29 |
P82 EARLY PROSTHETIC VALVE INFECTIVE ENDOCARDITIS (EPVIE) IN A CARDIAC SURGERY REFERRAL HOSPITAL, 20062012, RIO DE JANEIRO, BRAZIL
|
Fernandes, R. |
|
2013 |
41 |
S1 |
p. S31- 1 p. |
artikel |
30 |
P54 ECHINOCOCCUS GRANULOSUS INFECTIVE ENDOCARDITIS. A RARE PRESENTATION OF AN HELMINTH INFECTION
|
Nacinovich, F. |
|
2013 |
41 |
S1 |
p. S23- 1 p. |
artikel |
31 |
P29 EFFECT ON HOSPITAL LENGTH OF STAY FOR CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS FOLLOWING IMPLEMENTATION OF AN EVIDENCE-BASED TREATMENT ALGORITHM
|
Nagpal, A. |
|
2013 |
41 |
S1 |
p. S15- 1 p. |
artikel |
32 |
P21 FATAL OUTCOME OF MITRAL NATIVE VALVE ENDOCARDITIS DUE TO MISDIAGNOSIS AND USING HEPARIN
|
Soboleva, M. |
|
2013 |
41 |
S1 |
p. S13- 1 p. |
artikel |
33 |
P47 FEATURES OF INFECTIVE ENDOCARDITIS CAUSED BY AEROCOCCI
|
Rasmussen, M. |
|
2013 |
41 |
S1 |
p. S21- 1 p. |
artikel |
34 |
P20 FEATURES OF VEGETATION AND OUTCOME IN CHILDREN AND ADOLESCENTS WITH INFECTIVE ENDOCARDITIS
|
Soboleva, M. |
|
2013 |
41 |
S1 |
p. S13- 1 p. |
artikel |
35 |
P09 FIBRIN DEPOSITION DUE TO STAPHYLOCOCCUS AUREUS COAGULASE ACTIVITY CONTRIBUTES TO THE PATHOGENESIS OF S. AUREUS CATHETER INFECTIONS
|
Vanassche, T. |
|
2013 |
41 |
S1 |
p. S9-S10 2 p. |
artikel |
36 |
P45 FUNGAL ENDOCARDITIS: EARLY DIAGNOSIS AIMING AT BETTER OUTCOME AND PREDICTORS OF MORTALITY
|
Meshaal, M. |
|
2013 |
41 |
S1 |
p. S20- 1 p. |
artikel |
37 |
P46 FUNGAL ENDOCARDITIS – REVIEW OF NINE CASES
|
Pikelj Pečnik, A. |
|
2013 |
41 |
S1 |
p. S20-S21 2 p. |
artikel |
38 |
P51 GRANULICATELLA SPP. ENDOCARDITIS: CASE SERIES
|
Siciliano, R.F. |
|
2013 |
41 |
S1 |
p. S22- 1 p. |
artikel |
39 |
P93 HAEMOPHILUS SPECIES ENDOCARDITIS: A CASE REPORT
|
Gorup, L. |
|
2013 |
41 |
S1 |
p. S34- 1 p. |
artikel |
40 |
P67 24H-CEFUROXIME CAN BE SUFFICIENT FOR ANTIMICROBIAL PROPHYLAXIS IN CARDIAC SURGERY
|
Gonzalez, J. |
|
2013 |
41 |
S1 |
p. S26-S27 2 p. |
artikel |
41 |
P13 HEALTHCARE-ASSOCIATED INFECTIVE ENDOCARDITIS: ANALYSIS OF CASES AT A CARDIAC SURGERY REFERRAL HOSPITAL, RIO DE JANEIRO, BRAZIL, 2006–2011
|
Francischetto, O. |
|
2013 |
41 |
S1 |
p. S11- 1 p. |
artikel |
42 |
P89 HEART TRANSPLANTATION FOR COMPLICATED INFECTIVE ENDOCARDITIS
|
Aymami, M. |
|
2013 |
41 |
S1 |
p. S33- 1 p. |
artikel |
43 |
P63 HISTOPATHOLOGICAL FINDINGS IN CARDIAC VALVES SURGICALLY REMOVED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS
|
Siciliano, R.F. |
|
2013 |
41 |
S1 |
p. S25-S26 2 p. |
artikel |
44 |
P26 HOMOCYSTEINE IN INFECTIVE ENDOCARDITIS
|
Iossa, D. |
|
2013 |
41 |
S1 |
p. S14-S15 2 p. |
artikel |
45 |
P62 IMMUNIZATION OF RATS WITH LACTOCOCCUS LACTIS EXPRESSING CLUMPING FACTOR A PROTECTS FROM STAPHYLOCOCCUS AUREUS EXPERIMENTAL ENDOCARDITIS INDUCED BY LOW–GRADE BACTEREMIA
|
Veloso, T.R. |
|
2013 |
41 |
S1 |
p. S25- 1 p. |
artikel |
46 |
P81 IMPACT OF VALVE SURGERY IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND NEUROLOGICAL COMPLICATIONS
|
Selton-Suty, C. |
|
2013 |
41 |
S1 |
p. S31- 1 p. |
artikel |
47 |
P33 IMPLANTABLE CARDIAC-DEVICE INFECTIONS
|
Logar, M. |
|
2013 |
41 |
S1 |
p. S16-S17 2 p. |
artikel |
48 |
P48 INFECTIVE ENDOCARDITIS CAUSED BY NEISSERIA MUCOSA
|
Logar, M. |
|
2013 |
41 |
S1 |
p. S21- 1 p. |
artikel |
49 |
P01 INFECTIVE ENDOCARDITIS: EPIDEMIOLOGICAL AND THERAPEUTIC ASPECTS IN AN URBAN POPULATION – ROME, ITALY. RETROSPECTIVE STUDY
|
Ricciardi, A. |
|
2013 |
41 |
S1 |
p. S7- 1 p. |
artikel |
50 |
P57 INFECTIVE ENDOCARDITIS OF PROSTHETIC MITRAL VALVE, CAUSED BY ACINETOBACTER BAUMANNII
|
Kica, Arjana |
|
2013 |
41 |
S1 |
p. S24- 1 p. |
artikel |
51 |
P59 INFLUENZA A (H1N1) INFECTION AND PERICARDIAL EFFUSION IN A 50-YEAR-OLD WOMEN: A CASE REPORT
|
Knežević Praveček, M. |
|
2013 |
41 |
S1 |
p. S24- 1 p. |
artikel |
52 |
P78 INVOLVEMENT OF THE SPLEEN IN INFECTIVE ENDOCARDITIS, AGGRESSIVE SURGICAL TREATMENT IS INDICATED IN SPLENIC ABSCESS
|
Mestres, C.A. |
|
2013 |
41 |
S1 |
p. S30- 1 p. |
artikel |
53 |
P42 ISOLATION AND ANTIMICROBIAL RESISTANCE OF STAPHYLOCOCCUS AUREUS STRAINS
|
Hila, N. |
|
2013 |
41 |
S1 |
p. S19- 1 p. |
artikel |
54 |
P74 IS TRIPLE THERAPY NECESSARY IN STAPHYLOCOCCAL PROSTHETIC VALVE ENDOCARDITIS?
|
Plata, A. |
|
2013 |
41 |
S1 |
p. S29- 1 p. |
artikel |
55 |
P86 LONG–TERM RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH INFECTIVE VALVE ENDOCARDITIS
|
Ivanov, V.A. |
|
2013 |
41 |
S1 |
p. S32- 1 p. |
artikel |
56 |
P91 MINIMALLY INVASIVE SURGERY: AN INNOVATIVE TREATMENT FOR INFECTIVE ENDOCARDITIS
|
Jaramillo, N. |
|
2013 |
41 |
S1 |
p. S34- 1 p. |
artikel |
57 |
P11 MYOCARDIAL ABSCESS AND SUPPURATIVE PERICARDITIS CAUSED BY GROUP B BETA-HAEMOLYTIC STREPTOCOCCI
|
Vargovic, M. |
|
2013 |
41 |
S1 |
p. S10- 1 p. |
artikel |
58 |
P53 NEISSERIA GONORRHOEAE INFECTIVE ENDOCARDITIS. A CASE REPORT
|
Querci, M. |
|
2013 |
41 |
S1 |
p. S22-S23 2 p. |
artikel |
59 |
P70 NEPHROTOXICITY DURING AMINOGLYCOSIDE THERAPY FOR ENDOCARDITIS
|
Johansson, N. |
|
2013 |
41 |
S1 |
p. S27-S28 2 p. |
artikel |
60 |
P39 NEW SYSTEM OF MICROARRAY–BASED DETECTION OF BACTERIAL PATHOGENS IN HEART TISSUE SAMPLES
|
Freiberger, T. |
|
2013 |
41 |
S1 |
p. S18- 1 p. |
artikel |
61 |
P75 OUTCOME OF EARLY VALVE SURGERY COMPARED TO MEDICAL TREATMENT IN INFECTIVE ENDOCARDITIS COMPLICATED WITH EMBOLIC STROKE
|
Baršić, B. |
|
2013 |
41 |
S1 |
p. S29- 1 p. |
artikel |
62 |
P77 OUTCOME OF PATIENTS WITH INFECTIVE ENDOCARDITIS AND LIVER CIRRHOSIS: THE FATE OF OPERATED AND NON–OPERATED PATIENTS
|
Mestres, C.A. |
|
2013 |
41 |
S1 |
p. S29-S30 2 p. |
artikel |
63 |
P08 PANCARDITIS AND BACTEREMIA BY STAPHYLOCOCCUS AUREUS
|
Molinero Abad, S. |
|
2013 |
41 |
S1 |
p. S9- 1 p. |
artikel |
64 |
P22 PARAVALVULAR ABSCESS IN INFECTIVE ENDOCARDITIS: 30 YEARS EXPERIENCE
|
Rouze, S. |
|
2013 |
41 |
S1 |
p. S13-S14 2 p. |
artikel |
65 |
P25 PLASMA CHOLINESTERASE ACTIVITY IN CHILDREN WITH INFECTIVE ENDOCARDITIS
|
Popović, L. |
|
2013 |
41 |
S1 |
p. S14- 1 p. |
artikel |
66 |
P36 PRELIMINARY STUDY ON THE DIAGNOSTIC VALUE OF PET–CT SCAN IN CARDIOVASCULAR INFECTIONS
|
Utili, R. |
|
2013 |
41 |
S1 |
p. S17- 1 p. |
artikel |
67 |
P04 PREVALENCE OF ENDOCARDITIS AMONG PATIENTS WITH PROSTHETIC HEART VALVES AND STAPHYLOCOCCUS AUREUS BACTEREMIA
|
Palraj, B.R. |
|
2013 |
41 |
S1 |
p. S8- 1 p. |
artikel |
68 |
P88 PROMPT SYSTEM EXTRACTION DECREASES MORTALITY IN PATIENTS WITH CARDIOVASCULAR IMPLANTABLE ELECTROPHYSIOLOGIC DEVICE INFECTION
|
Le, K.Y. |
|
2013 |
41 |
S1 |
p. S33- 1 p. |
artikel |
69 |
P31 PROSPECTIVE STUDY OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTIVE ENDOCARDITIS
|
Mattucci, I. |
|
2013 |
41 |
S1 |
p. S16- 1 p. |
artikel |
70 |
P19 REVIEW OF INFECTIOUS ENDOCARDITIS IN OUR HOSPITAL IN 2008–2012
|
Molinero Abad, S. |
|
2013 |
41 |
S1 |
p. S13- 1 p. |
artikel |
71 |
P17 RISING INCIDENCE OF INFECTIVE ENDOCARDITIS ASSOCIATED WITH INJECTING DRUG USE – A MAJOR REGIONAL CENTRE EXPERIENCE FROM 2003 TO 2012
|
Tung, M. |
|
2013 |
41 |
S1 |
p. S12- 1 p. |
artikel |
72 |
P15 RISK FACTORS AND MORTALITY RATES IN DIFFERENT GROUPS OF PATIENTS WITH INFECTIVE ENDOCARDITIS
|
Kovalev, S. |
|
2013 |
41 |
S1 |
p. S11-S12 2 p. |
artikel |
73 |
Program, International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections 19–21 May 2013, Dubrovnik, Croatia
|
|
|
2013 |
41 |
S1 |
p. viii-x nvt p. |
artikel |
74 |
P35 SCANT SUPPORT FOR USE OF THE DUKE CRITERIA IN MANAGEMENT DECISIONS ABOUT PATIENTS SUSPECTED OF INFECTIVE ENDOCARDITIS: A LITERATURE REVIEW
|
der Vaart, T.W. |
|
2013 |
41 |
S1 |
p. S17- 1 p. |
artikel |
75 |
P85 SORIN FREEDOM SOLO STENTLESS VALVE IN SURGICAL THERAPY OF AORTIC VALVE ENDOCARDITIS: INITIAL RESULTS AND MID–TERM FOLLOWUP
|
Rudez, I. |
|
2013 |
41 |
S1 |
p. S32- 1 p. |
artikel |
76 |
P79 SPLENECTOMY IN ACTIVE INFECTIVE ENDOCARDITIS: SIMULTANEOUS OR TWO STAGE PROCEDURE?
|
Binner, C. |
|
2013 |
41 |
S1 |
p. S30- 1 p. |
artikel |
77 |
P05 STAPHYLOCOCCUS AUREUS BACTEREMIA: FACTORS ASSOCIATED WITH INFECTIVE ENDOCARDITIS
|
Le Moing, V. |
|
2013 |
41 |
S1 |
p. S8- 1 p. |
artikel |
78 |
P06 STAPHYLOCOCCUS AUREUS INFECTION IN SURGICALLY TREATED ACUTE INFECTIVE ENDOCARDITIS: DIFFERENCES BETWEEN MULTIRESISTANT AND MULTISENSITIVE STRAINS?
|
Binner, C. |
|
2013 |
41 |
S1 |
p. S8-S9 2 p. |
artikel |
79 |
P03 STAPHYLOCOCCUS AUREUS IN THE AETIOLOGY OF INFECTIVE ENDOCARDITIS IN SLOVAKIA DURING THE LAST SIX YEARS
|
Kulkova, N. |
|
2013 |
41 |
S1 |
p. S7-S8 2 p. |
artikel |
80 |
P07 STAPHYLOCOCCUS AUREUS PROSTHETIC VALVE ENDOCARDITIS (SAPVE): CURRENT FEATURES DEPENDING ON TIME TO DIAGNOSIS
|
Sáez, C. |
|
2013 |
41 |
S1 |
p. S9- 1 p. |
artikel |
81 |
P50 STAPHYLOCOCCUS LUGDUNENSIS ENDOCARDITIS: MULTICENTER STUDY OF 17 CASES
|
Galvez-Acebal, J. |
|
2013 |
41 |
S1 |
p. S21-S22 2 p. |
artikel |
82 |
P52 STREPTOCOCCUS PYOGENES INFECTIVE ENDOCARDITIS
|
Siciliano, R.F. |
|
2013 |
41 |
S1 |
p. S22- 1 p. |
artikel |
83 |
P69 SUCCESSFUL TREATMENT OF ABIOTROPHIA DEFECTIVA ENDOCARDITIS WITH LINEZOLID
|
Stemberger, L. |
|
2013 |
41 |
S1 |
p. S27- 1 p. |
artikel |
84 |
P80 SURGERY FOR NATIVE INFECTIVE MITRAL VALVE ENDOCARDITIS: A CLEAR STATEMENT FOR MINIMALLY INVASIVE PROCEDURE
|
Binner, C. |
|
2013 |
41 |
S1 |
p. S30-S31 2 p. |
artikel |
85 |
P28 THE EFFECT OF EARLY DIAGNOSIS ON THE OUTCOME OF THE TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS (PVE)
|
Atzev, B. |
|
2013 |
41 |
S1 |
p. S15- 1 p. |
artikel |
86 |
P27 THE IMPACT OF PREOPERATIVE LIMB EMBOLISATION IN ACTIVE INFECTIVE LEFT-SIDED ENDOCARDITIS
|
Binner, C. |
|
2013 |
41 |
S1 |
p. S15- 1 p. |
artikel |
87 |
P37 THE IMPACT OF ROUTINE BRAIN CT ANGIOGRAPHY ON TREATMENT DECISION AND MORTALITY IN PATIENTS WITH INFECTIVE ENDOCARDITIS
|
Meshaal, M. |
|
2013 |
41 |
S1 |
p. S18- 1 p. |
artikel |
88 |
P76 THE IMPACT OF VALVE SURGERY ON MORTALITY IN INFECTIVE ENDOCARDITIS COMPLICATED WITH EMBOLIC STROKE: A PROPENSITY SCORE ANALYSIS
|
Baršić, B. |
|
2013 |
41 |
S1 |
p. S29- 1 p. |
artikel |
89 |
P64 THE INTERACTION OF DNA – AND RNA–CONTAINING VIRUSES WITH CULTURES OF BONE MARROW MESENCHYMAL STEM CELLS AND CARDIOMYOCYTE PRECURSOR CELLS PREPARED FROM THESE CELLS
|
Koran, S. |
|
2013 |
41 |
S1 |
p. S26- 1 p. |
artikel |
90 |
P56 THE NEW PROFILE OF GRAM-NEGATIVE BACILLI PROSTHETIC VALVE ENDOCARDITIS
|
Hernández, M. |
|
2013 |
41 |
S1 |
p. S23-S24 2 p. |
artikel |
91 |
P73 THE PROLONGED USE OF ONCE DAILY AMINOGLYCOSIDES IS SAFE AND EFFECTIVE IN THE TREATMENT OF ENTEROCOCCAL ENDOCARDITIS
|
Patrat-Delon, S. |
|
2013 |
41 |
S1 |
p. S28-S29 2 p. |
artikel |
92 |
P90 THE ROLE OF SURGERY IN INFECTIVE ENDOCARDITIS SIGNIFICANT IMPACT ON PROGNOSIS OF STAPHYLOCOCCAL ENDOCARDITIS
|
Lejko Zupanc, T. |
|
2013 |
41 |
S1 |
p. S33-S34 2 p. |
artikel |
93 |
P38 THE USE OF LEUKOCYTE SCINTIGRAPHY AND FDG–PET IN SEARCH FOR A PRIMARY FOCUS IN INFECTIVE ENDOCARDITIS; EXPERIENCES FROM A SINGLE TERTIARY HEART CENTRE
|
Bang Jespersen, C. |
|
2013 |
41 |
S1 |
p. S18- 1 p. |
artikel |
94 |
P87 TRANSAORTIC VALVE REPLACEMENT INFECTIVE ENDOCARDITIS, RISE OF A NEW ENTITY: CASE REPORT AND LITERATURE REVIEW
|
Miro, J.M. |
|
2013 |
41 |
S1 |
p. S32-S33 2 p. |
artikel |
95 |
P83 TREATMENT OF ARDS DURING STAPHYLOCOCCAL ENDOCARDITIS WITH EXTRACORPOREAL MEMBRANOUS OXYGENATION (ECMO)
|
Raffanelli, D. |
|
2013 |
41 |
S1 |
p. S31- 1 p. |
artikel |
96 |
P14 TREND OF INFECTIVE ENDOCARDITIS IN TWO UNIVERSITY HOSPITALS IN RIO DE JANEIRO, BRAZIL
|
Damasco, P.V. |
|
2013 |
41 |
S1 |
p. S11- 1 p. |
artikel |
97 |
P18 TRENDS IN RISK FACTORS AND AETIOLOGY OF 1053 CASES OF INFECTIVE ENDOCARDITIS WITHIN 28 YEARS IN SLOVAKIA (1984–2012)
|
Sokolova, J. |
|
2013 |
41 |
S1 |
p. S12-S13 2 p. |
artikel |
98 |
P84 VALVULOPLASTY VERSUS VALVE REPLACEMENT IN MITRAL–VALVE INFECTIVE ENDOCARDITIS: AN OBSERVATIONAL STUDY
|
Curlier, E. |
|
2013 |
41 |
S1 |
p. S32- 1 p. |
artikel |
99 |
SY.8.4 CAN WE REDUCE THE INCIDENCE OF HEALTH–CARE ASSOCIATED IE?
|
Mircó, J.M. |
|
2013 |
41 |
S1 |
p. S6-S7 2 p. |
artikel |
100 |
SY.3.1 CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS INVOLVING IMPLANTABLE CARDIAC DEVICES
|
Athan, E. |
|
2013 |
41 |
S1 |
p. S3- 1 p. |
artikel |
101 |
SY.7.3 COMBINATION THERAPY FOR GRAM-POSITIVES — WHAT ARE THE ADVANTAGES?
|
Baršić, B. |
|
2013 |
41 |
S1 |
p. S6- 1 p. |
artikel |
102 |
SY.7.1 CURRENT RESISTANCE IN GRAM-POSITIVES
|
Stefani, S. |
|
2013 |
41 |
S1 |
p. S5-S6 2 p. |
artikel |
103 |
SY.1.2 DIAGNOSTIC AND TREATMENT IMPLICATIONS OF DIFFERENT STRAIN AND MEC TYPES
|
Skov, R. |
|
2013 |
41 |
S1 |
p. S1- 1 p. |
artikel |
104 |
SY.4.4 EMBOLIZATIONS OF THE CENTRAL NERVOUS SYSTEM IS THERE MORE THAN WE OBSERVE?
|
Snygg-Martin, U. |
|
2013 |
41 |
S1 |
p. S4- 1 p. |
artikel |
105 |
SY.2.2 HIGH–DOSE DAPTOMYCIN IN THE THERAPY OF STAPHYLOCOCCAL INFECTIVE ENDOCARDITIS AND WHEN TO APPLY IT
|
Rybak, M.J. |
|
2013 |
41 |
S1 |
p. S2- 1 p. |
artikel |
106 |
SY.8.2 INCIDENCE OF INFECTIVE ENDOCARDITIS DUE TO VIRIDANS GROUP STREPTOCOCCI BEFORE AND AFTER PREVENTION GUIDELINES CHANGES
|
Baddour, L.M. |
|
2013 |
41 |
S1 |
p. S6- 1 p. |
artikel |
107 |
SY.7.2 MIC CREEP: DOES IT EXIST?
|
Gould, I.M. |
|
2013 |
41 |
S1 |
p. S6- 1 p. |
artikel |
108 |
SY.4.2 MODIFIERS OF SYMPTOMATIC EMBOLIC RISK IN INFECTIVE ENDOCARDITIS
|
Sohail, M.R. |
|
2013 |
41 |
S1 |
p. S3- 1 p. |
artikel |
109 |
SY.6.1 MULTIDRUG–RESISTANT PATHOGENS HOW BIG IS THE THREAT?
|
Mircó, J.M. |
|
2013 |
41 |
S1 |
p. S4-S5 2 p. |
artikel |
110 |
SY.5.4 NEW ENTITY: INFECTIVE ENDOCARDITIS AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
|
Pericás, J.M. |
|
2013 |
41 |
S1 |
p. S4- 1 p. |
artikel |
111 |
SY.5.2 OPTIMAL TIMING FOR CARDIAC SURGERY IN INFECTIVE ENDOCARDITIS IS EARLIER THE BETTER?
|
Delahaye, F. |
|
2013 |
41 |
S1 |
p. S4- 1 p. |
artikel |
112 |
SY.6.3 PRESENT CHALLENGES IN THE TREATMENT OF FUNGAL ENDOCARDITIS
|
Tattevin, P. |
|
2013 |
41 |
S1 |
p. S5- 1 p. |
artikel |
113 |
SY.3.2 REMOVAL OF INFECTED DEVICES STRATEGIES AND RISKS
|
Wilkoff, B.L. |
|
2013 |
41 |
S1 |
p. S3- 1 p. |
artikel |
114 |
SY.4.1 THE ROLE OF HEMOSTASIS IN INFECTIVE ENDOCARDITIS
|
Durante-Mangoni, E. |
|
2013 |
41 |
S1 |
p. S3- 1 p. |
artikel |
115 |
SY.2.3 UNDERSTANDING AND CIRCUMVENTING DAPTOMYCIN RESISTANCE IN TREATMENT OF STAPHYLOCOCCAL ENDOCARDITIS
|
Bayer, A.S. |
|
2013 |
41 |
S1 |
p. S2- 1 p. |
artikel |
116 |
SY.1.1 UNDERSTANDING STAPHYLOCOCCUS AUREUS EPIDEMIOLOGY
|
Friedrich, A.W. |
|
2013 |
41 |
S1 |
p. S1- 1 p. |
artikel |
117 |
SY.6.2 WHAT IS NEW IN THE PATHOGENESIS AND TREATMENT OF ENTEROCOCCAL ENDOCARDITIS
|
Murray, B.E. |
|
2013 |
41 |
S1 |
p. S5- 1 p. |
artikel |
118 |
SY.1.3 WHOLE GENOME SEQUENCING AND MRSA PATHOGENESIS
|
Westh, H. |
|
2013 |
41 |
S1 |
p. S1- 1 p. |
artikel |